William Plovanic
Stock Analyst at Canaccord Genuity
(3.51)
# 903
Out of 4,918 analysts
139
Total ratings
48%
Success rate
4.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Buy | $139 → $170 | $164.98 | +3.04% | 11 | Aug 1, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 | $76.25 | +39.02% | 7 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $75 → $81 | $80.09 | +1.14% | 27 | Jul 25, 2025 | |
| GMED Globus Medical | Maintains: Buy | $97 → $90 | $53.63 | +67.82% | 4 | Jul 22, 2025 | |
| ANGO AngioDynamics | Maintains: Buy | $15 → $17 | $8.70 | +95.40% | 7 | Jul 16, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $129 → $142 | $128.50 | +10.51% | 6 | Jul 15, 2025 | |
| AORT Artivion | Initiates: Buy | $35 | $32.06 | +9.17% | 1 | Jun 17, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $115 → $101 | $92.40 | +9.31% | 3 | May 12, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $15.42 | +282.62% | 4 | May 1, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $7.55 | +138.41% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $4.22 | +160.67% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $52 | $36.35 | +43.05% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $4.66 | +71.67% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $15.23 | +116.68% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $117 | $106.79 | +9.56% | 10 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $287.77 | +5.64% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $6.32 | +137.34% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $240.39 | +18.14% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $14.87 | +68.12% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.65 | +627.27% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $85.34 | -17.98% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $18.49 | +159.60% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.19 | +425.06% | 3 | Jul 25, 2023 |
iRhythm Technologies
Aug 1, 2025
Maintains: Buy
Price Target: $139 → $170
Current: $164.98
Upside: +3.04%
DexCom
Aug 1, 2025
Maintains: Buy
Price Target: $106
Current: $76.25
Upside: +39.02%
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $75 → $81
Current: $80.09
Upside: +1.14%
Globus Medical
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $53.63
Upside: +67.82%
AngioDynamics
Jul 16, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $8.70
Upside: +95.40%
TransMedics Group
Jul 15, 2025
Maintains: Buy
Price Target: $129 → $142
Current: $128.50
Upside: +10.51%
Artivion
Jun 17, 2025
Initiates: Buy
Price Target: $35
Current: $32.06
Upside: +9.17%
Zimmer Biomet Holdings
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $92.40
Upside: +9.31%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $15.42
Upside: +282.62%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $7.55
Upside: +138.41%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $4.22
Upside: +160.67%
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $36.35
Upside: +43.05%
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $4.66
Upside: +71.67%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $15.23
Upside: +116.68%
Feb 6, 2025
Maintains: Buy
Price Target: $101 → $117
Current: $106.79
Upside: +9.56%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $287.77
Upside: +5.64%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $6.32
Upside: +137.34%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $240.39
Upside: +18.14%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $14.87
Upside: +68.12%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.65
Upside: +627.27%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $85.34
Upside: -17.98%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $18.49
Upside: +159.60%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.19
Upside: +425.06%